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Epicritic Sensation in Cervical Spinal Cord Injury:
Diagnostic Gains Beyond Testing Light Touch
Inge-Marie Velstra,1 Marc Bolliger,2,5 Michael Baumberger,3 Johan Swanik Rietman,4 and Armin Curt2,5
Abstract
Applied as a bedside test of gross dorsal column function, the testing of light touch (LT) sensation is of high clinical value
in the diagnosis of human spinal cord injury (SCI). However, the assessment of overall dorsal column deficit by testing
only LT may be limited, because the dorsal column pathway conveys several large diameter afferent modalities (e.g.,
sensation of touch, two-point discrimination, and proprioception). Therefore, the objective of this study was to compare
the epicritic sensation assessed by LT, Semmes–Weinstein monofilament (SWM), and electrical perception threshold
(EPT) across cervical dermatomes (C3–C8) in individuals with cervical SCI. A multicenter cross-sectional study was
performed at 6 months after cervical SCI, applying combined measures of LT, SWM, and EPT, bilaterally over predefined
key sensory points (C3–C8). A total of 300 left- and right-sided dermatomes were tested for each outcome measure in 25
participants. The percentage agreement between classifications according to LT and SWM/EPT testing for all dermatomes
between C3 and C8 ranged from 95.5% to 36.2%. The degree of agreement showed considerably variable j coefficients
( - 0.1 ‡ kw £ 0.7) for each dermatome between C3 and C8. The additional measurements of epicritic sensation by SWM
and EPT increased sensitivity by detecting and quantifying differences in sensory thresholds above, at, and below the LT
level of injury. This is relevant for early clinical trials (phase 1/2), in which disclosing any biological activity of an
intervention may be revealed by subtle sensory changes that might gain a clinical relevance.
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Introduction
Testing of sensory function is essential to sufficientlymeasure the degree of dysfunction and recovery after acute
cervical spinal cord injury (C-SCI), which is paramount for setting
reasonable goals in rehabilitation, and for accurate stratification in a
clinical trial.1,2 However, difficulties arise in selecting outcome mea-
sures that can detect small changes to evaluate the success of reha-
bilitation, and to test the efficacy of new interventions, for the different
sensory modalities and in the interpretation of those test results.
Light touch (LT) and pinprick (PP) assessment examined ac-
cording to the International Standards for Neurological Classifi-
cation of Spinal Cord Injury (ISNCSCI)3 are used routinely during
neurological examination of sensibility in patients with a SCI.
However, the sensory assessment by the ISNCSCI might not be
sufficiently sensitive to monitor safety and/or to detect subtle
therapeutic benefits.4 Furthermore, it may not be able to elucidate
potential mechanisms of recovery.5 Therefore, additional quanti-
tative sensory assessments, such as the electrical perception
threshold (EPT) and the Semmes–Weinstein monofilament
(SWM), may be used in combination with LT and PP to improve
the sensitivity to discrete sensory changes and robustness of sen-
sibility examination in the clinic and in research.6–11 LT, SWM,
and EPT assess the posterior column pathway for detecting
thresholds for tactile cutaneous sensation and electrical cutaneous
sensation.7,12–14
So far, SWM remains the only internationally recognized hand-
held instrument specifically designed to control application force
variables, and to meet sensitivity and repeatability requirements for
an objective outcome measure of sensation.10,15–17 However, to the
best of our knowledge, SWM has not been systematically applied in
spinal cord disorders,18 whereas clinical experience in peripheral
nerve damage (i.e., nerve repair surgery in upper extremities) has
proven its validity and is well established in clinical use.17,19
The pocket version of SWM consists of five nylon monofila-
ments with variable stiffness, which apply different amount of grams
to quantify cutaneous sensation. The SWM sensory threshold is
defined as the force of the lightest filament at which the patient
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2Spinal Cord Injury Centre, Balgrist University Hospital, Zurich, Switzerland.
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4Roessingh Research and Development, Laboratory of Biomechanical Engineering, University of Twente, Enschede, The Netherlands.
5European Multicenter Study about Human Spinal Cord Injury (EM SCI), Zurich, Switzerland.
JOURNAL OF NEUROTRAUMA 30:1342–1348 (August 1, 2013)
ª Mary Ann Liebert, Inc.
DOI: 10.1089/neu.2012.2828
1342
reports sensation. In participants with chronic C-SCI, the SWM has
been reported to have high validity and excellent overall inter- and
intra-tester reliability (intraclass correlation coefficient [ICC] ran-
ged between 0.84 and 0.95).8 However, the ICC between individual
cervical dermatomes has not been reported. Recently it has been
shown that the ICC is fair for the SWM in C4, T1, T8, and L4
dermatomes in healthy subjects.20 However, ICC values can vary
between healthy subjects and patients as a result of inter-individual
variations of sensory thresholds as well as differences in sensibility
between dermatomes. The determination of the SWM sensory
threshold has the advantage of being a simple and unobtrusive/
discreet method.
EPT testing has been introduced in the assessment of sensory
function in spinal cord disorders, and holds promise in providing
sensitive readouts beyond the clinical scaling.7,12,21–23 The EPT is
defined as the lowest ascending electrical stimulus intensity ex-
pressed in mA at which the patient reports sensation.6,24 The overall
inter- and intra-tester reliabilities of EPT appear to be moderate to
good in healthy participants20,21 and participants with incomplete
SCI.24 However, the ICC varied considerably between individual
dermatomes in healthy participants.23 Therefore, there are different
normative values for each dermatome. The EPT can be applied to
all sensory dermatomes, and results can be interpreted quickly;
however, the method is more time consuming than LT testing.
The LT assessment of sensation roughly grades the ability of
detecting an LT in the affected dermatome by ‘‘absent,’’ ‘‘im-
paired,’’ or ‘‘normal.’’ Therefore, detection of subtle improvements
in sensation or minor sensory impairments is impossible. The SWM
and EPT contain a greater range of discernible response levels for
detecting a tactile cutaneous sensation and electrical stimulation
and, therefore, have the potential of being more sensitive.22,25 This
encompasses a wide range of degrees of impairment, and can in-
clude hypersensitivity as well as hyposensitivity. However, it is
unknown if EPT or SWM are more sensitive than is clinical sensory
examination (LT) for an individual cervical dermatome.
Although SCI physicians and clinicians have gained great ex-
perience of LT testing in the clinical management of patients with
SCI, the actual sensitivity of LT testing to assess dorsal column
function in patients with SCI is less established. To our knowledge,
there is no study that compares epicritic sensation assessed by LT,
SWM, and EPT across cervical dermatomes (C3–C8) in partici-
pants at 6 months after C-SCI. The following study hypothesized
that the segmental assessment of epicritic sensation in human SCI
can be improved by additional semiquantitative sensory measures
complementary to LT. The latter findings are required for consid-
eration if LT testing can be assumed sensitive enough in inter-
ventional studies.
Methods
Study design
This study was a cross-sectional multicenter study in two spe-
cialized SCI rehabilitation centers.
Study population
Participants were recruited betweenMarch 2010 andMay 2011
from two Swiss SCI centers: the University Hospital Balgrist,
Zurich and the Swiss Paraplegic Center, Nottwil. Inclusion cri-
teria consisted of traumatic or nontraumatic C-SCI with an
American Spinal Injury Association (ASIA) Impairment Scale
(AIS) grade A, B, C, or D.3 Exclusion criteria were any accom-
panying severe neurological (e.g., traumatic brain injury) or
medical disorders and being < 16 years of age. The participants
were enrolled after having providing written informed consent.
The local ethics committees of the two participating centers
approved the study.
Procedures
The assessors were clinicans (physicians and occupational
therapists) who had long-term experience in working with indi-
viduals with SCI. To ensure high-quality and reliable examinations,
assessors were trained to perform all applied outcome measures. A
standardized protocol that outlined detailed instructions on per-
forming the assessments was followed for each outcome measure.
The recording techniques and materials were standardized across
both centers. All participants were tested in a quiet room
throughout the examinations. For EPT and LT testing, participants
were lying in a comfortable supine position, and for SWM testing,
participants were seated. First, the testing procedure was explained
to the participants. Before testing of cervical dermatomes, the
stimuli of the different outcome measures were applied to a der-
matome with normal sensation, such as the face, in order for the
patient to recognize the sensation. Subsequently, the participants
were asked to close both of their eyes, and the testing was started.
All outcome measures were assessed in a random order at 6 months
after SCI (defined as a time window between 150 and 186 days).
Assessments
The SWM and EPT outcome measures were applied bilaterally
over predefined ASIA sensory key points in the dermatomes C3 to
C8. The clinical neurological examination of touch sensation was
assessed by the ASIA LT testing according to the ISNCSCI pro-
tocol for the whole body.3 The PP assessment involves the anterior
column pathway (i.e., spino-thalamic fiber tracts) and is, therefore,
not included in the present study. Appreciation of LT sensation at
each of the ASIA sensory key points was scored on an ordinal three
point scale as follows: 2= normal; 1= impaired, and 0= absent. The
LT level of lesion was defined as the last intact sensory level as
indicated by normal LT testing.3
The tactile cutaneous sensation threshold was assessed by the
pocket version of SWM10 (North Coast Medical, Inc, Campbell,
Canada) according to a strict and standardized assessment proto-
col.10 The sensory threshold of the SWMwas defined as the force of
the lightest filament at which the individual reported sensation. An
ascending method of threshold testing was used, starting with the
smallest diameter monofilament (lightest filament, lowest force,
most difficult to detect) and continuing in order of increasing di-
ameter if the patient did not respond to the previous filament. Only
ASIA sensory key point locations, which did not respond to the
previous filament, were tested with the next filament. The exami-
nation was continued until the patient recognized a force/touch in
all test locations or until it was established that the patient did not
feel even the heaviest filament. Two of three applications of the
lightest filament had to be felt to obtain a positive result. All
the other, heavier filaments were applied only once according to the
manufacturer’s instructions.10 In the study of Voerman et al.,13
filament marking 3.61 represented the normal value for sensory
thresholds in all cervical dermatomes. In the present study the
qualification of normal values was based on the mean threshold and
the 95% CI according to Voerman et al.13 The log of grams of force
was represented by numeric values ranging from 0 to 4 as described
in the instructions of the SWM mini-kit: 4 =filament 3.61; 3= fil-
ament 4.31; 2= filament 4.56; 1 =filament 6.65; and 0 = no re-
sponse.10,13,16 In our study, a SWM value of 1, 2, or 3 points was
defined as impaired, a value of 4 points was defined as normal, and
a value of 0 points was defined as absent.
The EPT6,22 was assessed according to previous studies,6,22
using a modified mobile Compex 2 stimulator (Compex Medical
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SA, Switzerland), which delivered a square shaped stimulus of
0.5ms duration at 3Hz. The perceptual threshold was defined as
the lowest ascending stimulus intensity (mA) at which the patient
reported sensation. The maximal stimulator output and the smal-
lest increment were adjusted to 26.9mA and 0.21mA, respec-
tively. The skin was thoroughly cleaned with alcohol wipes, and
disposable, self-adhesive electrocardiogram (ECG) electrodes
(cathode) with a diameter of 18mm (3M Red DotTM - type 2248)
were applied over the ASIA sensory key points. A large
(50· 90mm) inactive electrode (anode; Synapse Electrodes,
Ambu, Denmark) was attached to the forearm of the testing side.
For every dermatome tested, the stimulus intensity was manually
increased and decreased with changes applied exactly once per
second, until the patient first reported the sensation (ascending)
under the cathode. This was repeated three times, and the lowest
EPT (expressed in mA) of the three measurements was included in
the analysis. Van Hedel et al.23 have established the normal values
for the electrical perception threshold for each cervical derma-
tome. In our study, the qualification of normal values was based on
the mean value of the upper limits of the 95% CI from the two
measurements, which reflects normality according to van Hedel
et al.23 In the present study, an impaired EPT value was defined as
any value greater than the normative EPT value. A normal EPT
value was defined as any value equal or smaller than the normative
EPT value, and the EPT value was considered absent, if the
maximum current intensity (threshold at 8.4mA) was not per-
ceived. A stimulation > 8.4mA was avoided, as at this level of
intensity, additional pathways (i.e., nociceptive A-d or C-fibers)
than dorsal column fibers (i.e., A-b fibers) might become effec-
tively stimulated, and could falsify the perceived sensation by the
subjects.12
Statistical analysis
Descriptive statistics were used to determine the frequency,
median, and range of the study participants’ characteristics, in-
cluding cause of injury, AIS grade, AIS sensory LT level, sex, and
age. For comparison with LT scores, the study participants’ SWM
and EPT data were classified as normal, impaired, or absent, and
scored with 2, 1, or 0, respectively. All comparisons were made for
the right and left side combined, because there was no statistically
significant difference between the right and left side. Dermatomes
were classified as having abolished, impaired, or normal sensation
based on LT, SWM, and EPT testing. The frequency and percent-
age of classification agreement between LT-SWM and LT-EPT for
all C3 to C8 dermatomes was determined. Finally, the degree of
agreement between the three measures, weighted (Fleiss–Cohen) j
coefficients and CIs were calculated for each dermatome between
C3 and C8, as well as for all dermatomes between C3 and C8.
Agreement was assessed using the standards as established by
Altman: 0.00 = poor; 0.01–0.20 = slight; 0.21–0.40 = fair; 0.41–
0.60 =moderate; 0.61–0.80 = substantial; and 0.81–1.00 = almost
perfect.26
All data were analysed using SPSS version 18.0 for Windows
and R version 2.15.1 for Windows.
Results
Participants
Table 1 presents the characteristics of the 25 cervical SCI
participants with a high percentage of incomplete SCI. SCI was
scored as complete (AIS A) in 5 individuals and incomplete
in the remaining 20 individuals (AIS B, C, and D). In five in-
dividuals, the cervical dermatomes did not reveal any touch
sensation disturbance. A total of 300 left- and right-sided der-
matomes were tested for each outcome measure between C3 and
C8 in all 25 participants.
Distribution of findings in LT, SWM and EPT
Classification of dermatomes according to LT, SWM, and EPT
testing are shown in Figure 1. The greatest number of dermatomes
was classified as intact when using LT testing (62.7%), whereas
applying SWM (44.3%) and EPT (29.3%) revealed fewer intact
dermatomes. Accordingly, the number of dermatomes classified as
impaired increased from LT (30%) to SWM testing (42.3%), and
was greatest for EPT testing (57%) across dermatomes. The num-
ber of dermatomes classified as absent was rather similar for SWM
and EPT testing (30.3% and 30.7%), and lower for LT (7.3%).
Agreement of LT and SWM classification
The agreement of classification between LT and SWM for all
dermatomes between C3 and C8 is reported in Table 2. The overall
agreement of classifications comparing LT and SWM within the
same categories was 95.5% (21/22) for absent sensation, 47.8%
(43/90) for impaired sensation, and 54.3% (102/188) for normal
sensation. In dermatomes with absent LT sensation (LT 0), 4.5%
reported some SWM sensation. However in dermatomes with
preserved LT, either impaired (LT 1) or normal LT (LT 2), a high
degree of discordance was observed compared with SWM. In
dermatomes with normal LT, the SWM testing classified 44.1%
(83/188) of dermatomes as being impaired. All 83 dermatomes
classified by impaired SWM were at and above the LT level of
injury. In dermatomes classified with impaired LT scores, SWM
testing revealed normal or absent sensation in 34.4% (31/90) and
17.8% (16/90), respectively. All 31 dermatomes classified by
normal SWM were below the LT level of injury.
Table 1. Demographic and Clinical Characteristics
of Participants (n = 25)
Characteristics All participants
Cause of SCI
Traumatic 23 (92%)
Nontraumatic 2 (8%)
Site
Uniklinik Balgrist Zurich (CH) 3 (12%)
Swiss Paraplegic Centre Nottwil (CH) 22 (88%)
Sex
Females 5 (20%)
Males 20 (80%)
Age (years)
Median 56
Min-max 20–84
AIS
A 5 (20%)
B 3 (12%)
C 1 (4%)
D 16 (64%)
Sensory light touch level
C2 1 (4%)
C3 3 (12%)
C4 7 (28%)
C5 4 (16%)
C6 3 (12%)
C7 1 (4%)
C8 1 (4%)
Below C8 2 (8%)
No detectable light touch level 3 (12%)
SCI, spinal cord injury; N, sample size;
AIS, American Spinal Injury Association Impairment Scale.
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Agreement of LT and EPT classification
The agreement of classifications between LT and EPT for all
dermatomes between C3 and C8 are reported in Table 3. Overall,
the agreement between classifications examined by LT and EPT
testing was 90.9% (20/22) for absent of sensation, 52/90 (57.8%)
for impaired sensation, and 68/188 (36.2%) for normal sensation. A
high discordance of classifications for impaired and normal sen-
sation between LT and EPT was recorded in the remaining der-
matomes. In dermatomes with normal LT, the EPT testing
classified 62.2% (117/188) of dermatomes as being impaired. All
117 classified by impaired EPT were at and above the LT level of
injury. Furthermore, in dermatomes classified with impaired LT
scores, EPT testing revealed normal sensation in 22.2% (20/90) and
an absent sensation in 20% (18/90). All 20 dermatomes classified
by normal EPT were below the LT level of injury.
Degree of agreement between LT-SWM and LT-EPT
Table 4 shows the level of classification agreement between LT-
SWM and LT-EPT for all dermatomes between C3 and C8. The
overall weighted j coefficient between LT and SWMwas moderate
(0.5) and fair (0.4) for LT-EPT. However, when evaluated for in-
dividual dermatomes the agreement varied considerably. In der-
matomes C3, C4, and C5, the weighted j coefficients ( £ 0.2)
revealed that the level of classification agreement between LT and
SWM, as well as between LT and EPT, occurred rather by chance.
However in dermatomes C6, C7, and C8, the weighted j coeffi-
cients were found to be moderate to substantial (weighted j
range = 0.5 to 0.7) between the different testing methods.
Discussion
The study reveals for the first time a comprehensive comparison
of epicritic sensation as assessed by LT, SWM, and EPT across
cervical dermatomes (C3–C8) in individuals with SCI. The sensory
testing focused on the assessment of sensory integrity of distinct
predefined dermatomes in patients with C-SCI. Improving the as-
sessment of epicritic sensation will be important in early clinical
trials (phase 1/2), in which segmental and subtle changes in sensory
function might provide important readouts about the beneficial as
well as the detrimental (i.e., descending and ascending levels of
lesion, respectively) effects of novel interventions. The presented
study provides evidence that the segmental assessment of epicritic
sensation can be improved by SWM and EPT.
The challenge of sensory testing
Clinical testing of sensory function is commonly challenged by
limitations of test reliability, which is true to some extent for almost
all sensory qualities (such as epicritic sensation and prothopatic
sensation).7,9,27,28 This becomes even more demanding when as-
sessing different levels of sensory impairment when the subjective
rating of patients is not able to define incremental levels of im-
pairment, but becomes rather limited to a simplified categorical
(ordinal scale, e.g., normal, impaired, and abolished sensation)
FIG. 1. Numbers and percentage of dermatomes in absent, im-
paired, and normal sensation for light touch (LT), Semmes–
Weinstein monofilament (SWM), and electrical perception
threshold (EPT). A total of 300 dermatomes for each outcome
measure between C3 and C8 were tested.
Table 2. Agreement and Discordance of Frequency of Classification in Absent, Impaired,
and Normal Sensation Between LT and SWM (300 Dermatomes)
Agreement
absent Discordance
Agreement
impaired Discordance
Agreement
normal Discordance
LT 0 &
SWM 0
LT 0 &
SWM 1
LT 0 &
SWM 2
LT 1 &
SWM 1
LT 1 &
SWM 0
LT 1 &
SWM 2
LT 2 &
SWM 2
LT 2 &
SWM 0
LT 2 &
SWM 1
Dermatome n n n n n n n n n
C3 0 0 0 1 0 0 27 0 22
C4 0 0 0 3 0 3 21 0 23
C5 0 0 0 5 1 11 17 0 16
C6 7 0 0 9 4 3 17 0 10
C7 6 0 0 14 5 9 9 0 7
C8 8 1 0 11 6 5 11 3 5
Overall 21 1 0 43 16 31 102 3 83
Overall percentage 95.5% 4.5% 0% 47.8% 17.8% 34.4% 54.3% 1.6% 44.1%
LT, light touch; SWM, Semmes–Weinstein monofilament.
SWM was grouped in three classes: SWM 0= 0, absent; SWM 1,2,3= 1, impaired; SWM 4= 2, normal.
LT 0, absent (22 dermatomes); LT 1, impaired (90 dermatomes); LT 2, normal (188 dermatomes).
n= Frequency of classification.
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gross scoring. Therefore, the ability to understand minor changes
during recovery (improvements or deterioration) is very challeng-
ing, and clinical testing of one specific sensory quality (such as LT)
within a complex domain of sensory function (such as epicritic
sensation conveyed by dorsal column pathways) will be likely of
limited sensitivity. One approach to overcome these challenges is
to introduce measures with a more defined scaling of sensation
(such as SWM testing by applying different sensory modalities) or
to combine complementary sensory measures that are considered to
reflect to some extent the integrity within similar fiber tracts. The
latter approach would require modalities that are not redundant, but
are able to reveal subtle differences regarding the integrity of
function within an entire sensory system. In this context, the ap-
plied measures should also represent the same anatomical areas
(i.e., distinct dermatomes), which can be well achieved by using
LT, SWM, and EPT testing.
Disparity and sensitivity
The value of combining sensory testing of EPT and SWM
complementary LT testing resides in the intention that they provide
different insights in the integrity or impairment of epicritic sensa-
tion. Accordingly, they should not be just redundant, but reveal
changes that cannot be disclosed by LT testing. A mismatch of
segmental epicritic sensation was observed, as SWMwas classified
in 44.1% dermatomes and EPT was classified in 62.2% derma-
tomes as impaired, whereas LT revealed normal response. Inter-
estingly, those findings were all at or above the LT level
according to ISNCSCI, and are for the EPT findings in accor-
dance to other studies.7,12,22,23 Another discrepancy of segmental
epicritic sensation was found below the level of injury according
to ISCNSCI. LT revealed impaired response, whereas SWM
classified 34.4% dermatomes and EPT classified 22.2% derma-
tomes as normal. These SWM findings are in agreement with the
results of Kalsi-Ryan et al.8 In their study, they used SWM in
individuals with chronic cervical SCI, and observed greater sen-
sitivity when using SWM, because of increased response levels,
compared with the values reported when using ISNCSCI LT. The
EPT findings are in line with the results of Kramer et al.,21 who
observed that individuals with cervical SCI have persisting EPT
values below the level of the lesion.22 The present results suggest
that SWM and EPT might be sensitive to small sensory impair-
ments and/or preserved innervation in sensory function above, at,
and below the LT level, which are less detectable by LT testing.
This degree of sensitivity could be required to assess differences
in sensory recovery, especially when improvements might be
limited to one or two dermatomes adjacent to the LT level. Ob-
viously, the value of additional sensory testing is most relevant in
Table 3. Agreement and Discordance of Frequency of Classification in Absent, Impaired
and Normal Sensation Between LT and EPT (300 Dermatomes)
Agreement
absent Discordance
Agreement
impaired Discordance
Agreement
normal Discordance
LT 0 &
EPT 0
LT 0 &
EPT 1
LT 0 &
EPT 2
LT 1 &
EPT 1
LT 1 &
EPT 0
LT 1 &
EPT 2
LT 2 &
EPT 2
LT 2 &
EPT 0
LT 2 &
EPT 1
Dermatome n n n n n n n n n
C3 0 0 0 1 0 0 22 0 27
C4 0 0 0 4 1 1 12 1 31
C5 0 0 0 11 6 0 4 1 28
C6 7 0 0 9 1 6 14 0 13
C7 6 0 0 15 5 8 8 0 8
C8 7 0 0 12 5 5 8 1 10
Overall 20 2 0 52 18 20 68 3 117
Overall percentage 90.9% 9.1% 0% 57.8% 20% 22.2% 36.2% 1.6% 62.2%
LT, light touch; EPT, electrical perception threshold.
EPT was grouped in three classes: maximum pain threshold of 8.4mA not perceived= 0, absent; greater than the normative EPT value= 1, impaired;
equal to or less than the normative EPT value= 2, normal.
LT 0, absent (22 dermatomes); LT 1, impaired (90 dermatomes); LT 2, normal (188 dermatomes).
n= Frequency of classification.
Table 4. Agreement of Classifications Between LT-SWM and LT-EPT for Each Dermatome Between C3 and C8
and for All Dermatomes Between C3 and C8
Dermatome Dermatome
C3 C4 C5 C6 C7 C8 Overall C3 - C8a
Agreement Kw(95%CI) Kw(95%CI) Kw(95%CI) Kw(95%CI) Kw(95%CI) Kw(95%CI) Agreement Kw(95%CI)
LT-SWM 0.0 ( - 0.2;0.2) 0.0 ( - 0.2;0.2) - 0.1 ( - 0.3;0.2) 0.7 (0.4;1.0) 0.6 (0.3;0.9) 0.5 (0.2;0.8) LT-SWM 0.5 (0.4;0.6)
LT-EPT 0.0 ( - 0.2;0.2) 0.1 ( - 0.2;0.3) 0.2 (0.0;0.5) 0.6 (0.3;0.9) 0.6 (0.3;0.8) 0.5 (0.2;0.8) LT-EPT 0.4 (0.3;0.5)
LT, light touch; SWM, Semmes–Weinstein monofilament; EPT, electrical perception threshold.
C3, cervical dermatome right and left side combined; Kw, weighted j coefficient (Fleiss-Cohen); 95% CI, the lower and upper limit of the 95%
confidence interval.
aC3-C8, all dermatomes between C3 to C8, right- and left side combined.
Weighted j coefficient: 0.00, poor; 0.01–.20, slight; 0.21–0.40, fair; 0.41–0.60, moderate; 0.61–0.80, substantial; and 0.81–1.00, almost perfect.
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dermatomes that are clinically considered to be normal or im-
paired. In dermatomes with abolished sensation, SWM and EPT
do not provide additional information to LT testing. (Overall
agreement for abolished C3–C8 dermatomes between LT and
SWM/EPT testing was *95.5% and 90.9%, respectively.)
Statistical analysis (kw £ 0.5) confirmed that there is only a
limited congruency between the three different assessments ad-
dressing epicritic sensation. Interestingly, these findings were not
uniform across all dermatomes, and revealed a higher percentage
of congruency (moderate to substantial agreement) specifically in
the C6, C7, and C8 dermatomes, where a higher percentage of
absent sensation was found with all three testing methods. Fur-
thermore, in the C3, C4, and C5 dermatomes, a higher percentage
of impaired and normal sensation was reported, which revealed a
poor agreement between the three different assessments. These
findings emphasize, as has been shown by the different thresh-
olds for SWM and EPT across these dermatomes, that clinical
assessment using LT is of limited sensitivity to disclose seg-
mental differences in sensory function. Differences in findings
across cervical (and thoracic) dermatomes are not specific for
epicritic sensation, but have been also shown for the assessment
of spinothalamic function (i.e., using laser-evoked potentials or
contact heat evoked potentials), which reveals marked difference
between dermatomes (again these differences between derma-
tomes are also not adequately reflected by the clinical testing of
PP sensation).29,30
Improving readouts of sensory plasticity
The aims of increasing the sensitivity of testing epicritic sen-
sation after SCI are twofold: 1) to identify changes within derma-
tomes, that is, high resolution of segmental changes, and 2) to
provide insight into specific pathways that for the epicritic sensa-
tion are characterized by their high level of myelination. Therefore,
applying such measures in an interventional study can address if
segmental changes occur that are beyond spontaneous or regular
findings (both beneficial and detrimental). In addition, such mea-
sures might be useful if interventions are considered to improve the
myelination (i.e., concept of re-myelination) of damaged spinal
fibers, where the recovery of A-b fibers depend on high level of
myelination and might reveal superior recovery than less or un-
myelinated sensory fibers (such as C fibers).31,32 Therefore, in
clinical trials, an improved resolution of sensory function by
combined LT and SWM/EPT testing could be meaningful in re-
vealing subtle changes that, for a proof of mechanism, might be
critical for entering a next phase in which these effects can be
amplified by adjusting the intervention.
Conclusion
There is limited agreement on sensory testing, specifically in
incompletely affected dermatomes, among testing of LT, SWM,
and EPT. This difference is likely attributable to the measure-
ment limitations of each testing, and that they individually re-
spond to the differently affected sensory modalities within the
epicritic sensation.28 The results show that SWM and EPT testing
can add complementary resolution to LT testing at 6 months after
C-SCI by detecting and quantifying differences in sensory
thresholds above, at, and below the LT level of injury. The
ability of combined sensory testing to gain insights beyond LT
warrants consideration in the protocol design of interventional
studies in which the sensitivity to indicate even subtle differences
is of value both in the stratification of patients and the potential
(not shown here) to reveal an improved responsiveness in sensory
testing.
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